Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

Laboratory Report

Patient
Name: Antonini, Carmelo
DOB: 05-MAY-1992 (Age: 33)
Gender: male
Address:
Strada Pietrangeli, 17 Piano 9
28898 Cana (Italy)
ID: 5781-223385-6 (ECI)
Report
Date: 04-FEB-2023
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Azienda Ospedaliera Sant'Antonio Abate - Gallarate
Via Eusebio Pastori 4
21013 Gallarate (Italy)
Specimen
Collected: 04-FEB-2023

Chemistry

Test 04-FEB-2023 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 157.8 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 140.6 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 69.4 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 60.3 H 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
Lipid profile is within normal limits, with total cholesterol, triglycerides, and LDL all in the desirable range. HDL cholesterol is slightly above the upper reference limit, which is not clinically concerning and may be protective. No laboratory evidence of dyslipidemia. No further action required from a laboratory perspective.